Bert Vogelstein
Johns Hopkins University
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Cancer Immunotherapy and Biomarkers
Strong evidence · 3 supporting papers · latest 2026
Immunotherapy and Immune Responses
Strong evidence · 2 supporting papers · latest 2021
CAR-T cell therapy research
Solid evidence · 1 supporting paper · latest 2021
Lung Cancer Treatments and Mutations
Solid evidence · 1 supporting paper · latest 2026
Lymphoma Diagnosis and Treatment
Solid evidence · 1 supporting paper · latest 2021
Lung Cancer Research Studies
Supporting evidence · 1 supporting paper · latest 2026
Publications (3)
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
2021DOIPMID 34290408
Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
2021DOIPMID 34608287
Prophylactic peptide vaccine targeting resistance mutations in advanced ALK-positive lung cancer: Primary analysis from the ARCHER trial.
2026DOI
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Johns Hopkins University
Source: OpenAlex · retrieved 2026-09-29